Someone wants them and at 3 cents could be a good deal. ~$30million MD post dilution is cheap for a bio for the products they got if they realise some potential. With this and the line of credit should put them in good stead for commercialisation.
- Forums
- ASX - By Stock
- rights issue
Someone wants them and at 3 cents could be a good deal....
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online